MEDIATION BY 5-HYDROXYTRYPTAMINE(2B) RECEPTORS OF ENDOTHELIUM-DEPENDENT RELAXATION IN RAT JUGULAR-VEIN

被引:81
作者
ELLIS, ES [1 ]
BYRNE, C [1 ]
MURPHY, OE [1 ]
TILFORD, NS [1 ]
BAXTER, GS [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AD,ESSEX,ENGLAND
关键词
5-HT(2B) RECEPTORS; VASCULAR; ENDOTHELIUM; SB; 200646; BW; 723C86;
D O I
10.1111/j.1476-5381.1995.tb13240.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 An 'atypical' 5-HT2 receptor which is located on the endothelium of rat jugular vein has been described. In the present study we have further defined the nature of the 5-HT2 receptor subtype present in this preparation. 2 In experiments conducted in the presence of ketanserin to preclude involvement of 5-HT2 receptors, the mixed 5-HT2B/(2C) antagonist, SB 200646, acted as an antagonist of 5-HT at the endothelial 5-HT receptor (pA(2) = 7.2). Yohimbine, which exhibits negligible affinity for rat 5-HT2C, receptors but has high 5-HT2B receptor affinity, acted as a potent but non-surmountable antagonist (pA(2) greater than or equal to 7.3) in rat jugular vein. Neither yohimbine nor SB 200646 affected endothelium-dependent relaxations induced by carbachol. 3 Mianserin also acted as a surmountable antagonist (pA(2) = 7.3) and the 5-HT2B agonist, BW 723C86, acted as a potent partial agonist (pEC(50) [95% C L], intrinsic activity +/- s.e.mean = 7.9 [7.6-8.3], 0.84 +/- 0.04). Responses to BW 723C86 were antagonized by SB 200646 (0.3 mu M) yielding an 'apparent' pA(2) [95% CL] of 7.03 [6.76-7.32]. 4 These data are consistent with the presence of 5-HT2B receptors mediating endothelium-dependent relaxation of rat jugular vein.
引用
收藏
页码:400 / 404
页数:5
相关论文
共 17 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   FURTHER CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE RECEPTORS (PUTATIVE 5-HT2B) IN RAT STOMACH FUNDUS LONGITUDINAL MUSCLE [J].
BAXTER, GS ;
MURPHY, OE ;
BLACKBURN, TP .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :323-331
[3]  
BODELSSON M, 1992, J PHARMACOL EXP THER, V264, P709
[4]  
CLINESCHMIDT BV, 1985, J PHARMACOL EXP THER, V235, P696
[5]  
Ellis E. S., 1994, British Journal of Pharmacology, V112, p477P
[6]   N-(1-METHYL-5-INDOLYL)-N'-(3-PYRIDYL)UREA HYDROCHLORIDE - THE 1ST SELECTIVE 5-HT(1C) RECEPTOR ANTAGONIST [J].
FORBES, IT ;
KENNETT, GA ;
GADRE, A ;
HAM, P ;
HAYWARD, CJ ;
MARTIN, RT ;
THOMPSON, M ;
WOOD, MD ;
BAXTER, GS ;
GLEN, A ;
MURPHY, OE ;
STEWART, BA ;
BLACKBURN, TP .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (08) :1104-1107
[7]   EFFECT OF MIANSERIN, A POTENT ANTI-SEROTONIN AGENT, ON ISOLATED RAT STOMACH FUNDUS PREPARATION [J].
FRANKHUYZEN, AL ;
BONTA, IL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 25 (01) :40-50
[8]  
GLUSA E, 1992, 5 HYDROXYTRYPTAMINE, P168
[9]   AN ENDOTHELIAL 5-HT RECEPTOR THAT MEDIATES RELAXATION IN GUINEA-PIG ISOLATED JUGULAR-VEIN RESEMBLES THE 5-HT1D SUBTYPE [J].
GUPTA, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (03) :703-709
[10]  
HOYER D, 1989, N-S ARCH PHARMACOL, V339, P252